Predictive Oncology Inc. (POAI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 124.62M |
| Enterprise Value | 115.5M |
| P/E Ratio | -0.07 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 35.97 |
| Price/Book Ratio | 5.9 |
| Enterprise/Revenue | 29.76 |
| Enterprise/EBITDA | -0.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -77.7 |
| Operating Margin | -9.54 |
| Return On Assets | -2.53 |
| Return On Equity | -22.73 |
| Revenue | 125,284 |
| Revenue/Share | 0.17 |
| Gross Profit | 52,662 |
| EBITDA | -232.17M |
| Net Income | -233.1M |
| Diluted EPS | -13.37 |
| Total Cash | 21.91M |
| Total Cash/Share | 1.11 |
| Total Debt | 1.24M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 1.45 |
| Book Value Per Share | 1.73 |
| 52-Week Change | -69.97 |
| 52-Week High | 45.9 |
| 52-Week Low | 1.21 |
| Moving Average 50 Days | 8.42 |
| Moving Average 200 Days | 13.27 |
| Average Volume | 141,651 |
| Shares Outstanding | 726,080 |
| % Held by Institutions | 1.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 30, 2025 |